Innovative Health Dx launches at-home, DTC diagnostic tests

By LabPulse.com staff writers

September 13, 2022 -- CLIA-certified lab operator Innovative Health Diagnostics announced on Tuesday the launch of two direct-to-consumer (DTC), at-home diagnostic tests, the Anti-Mullerian Hormone (AMH) test and COVID-19 Neutralizing Antibody (CNAB) test.

The AMH test measures anti-Mullerian hormone levels in an individual's body, providing a range for comparison, and is considered a good indicator of a person's ovarian reserve, the firm said.

Meanwhile, the CNAB test detects SARS-CoV-2 neutralizing antibodies and could be used to better understand the user's long-term immunity, Innovative added.

NIH to award up to $300M for next-generation COVID tests
The National Institutes of Health (NIH) on Thursday announced it will provide funding to diagnostic test manufacturers for the development of the next...
Quest Diagnostics sees decline in August COVID test demand
On the heels of nabbing a green light from the U.S. Food and Drug Administration for an Emergency Use Authorization of the first monkeypox PCR test, Quest...
Using the human voice to detect COVID, COPD
Artificial intelligence (AI) and a mobile phone app can be used to detect COVID-19 infection in the voice, according to researchers based in the Netherlands.
IHD, AIMA to develop at-home endometriosis test
Innovative Health Diagnostics (IHD) has partnered with Aima Laboratories to develop an at-home test that detects endometriosis.
Allara launches new hormone test for women
Allara has launched a test called Diagnostic Tool that can detect a set of hormonal and metabolic markers in women, providing clarity on symptoms like...

Copyright © 2022 LabPulse.com

Last Updated mp 9/13/2022 11:48:50 AM



Subscribe Today
Do you want to be a Microbiology Insider?

When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.

Yes, Keep Me Current